Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIII) Revenue (2020 - 2025)

Historic Revenue for P3 Health Partners (PIII) over the last 6 years, with Q3 2025 value amounting to $345.3 million.

  • P3 Health Partners' Revenue fell 465.89% to $345.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 214.53%. This contributed to the annual value of $1.5 billion for FY2024, which is 1848.43% up from last year.
  • P3 Health Partners' Revenue amounted to $345.3 million in Q3 2025, which was down 465.89% from $355.8 million recorded in Q2 2025.
  • Over the past 5 years, P3 Health Partners' Revenue peaked at $388.5 million during Q1 2024, and registered a low of $126.5 million during Q4 2021.
  • Over the past 5 years, P3 Health Partners' median Revenue value was $302.1 million (recorded in 2023), while the average stood at $287.9 million.
  • In the last 5 years, P3 Health Partners' Revenue skyrocketed by 8636.19% in 2022 and then tumbled by 616.34% in 2025.
  • P3 Health Partners' Revenue (Quarter) stood at $126.5 million in 2021, then soared by 104.07% to $258.2 million in 2022, then skyrocketed by 34.33% to $346.9 million in 2023, then increased by 6.87% to $370.7 million in 2024, then fell by 6.86% to $345.3 million in 2025.
  • Its Revenue stands at $345.3 million for Q3 2025, versus $355.8 million for Q2 2025 and $373.2 million for Q1 2025.